Last reviewed · How we verify
CHAPLE disease
Approved treatments
- Veopoz · Regeneron
Veopoz works by blocking the activity of Complement C5, a protein that contributes to inflammation. - VEOPOZ · REGENERON PHARMACEUTICALS
Pozelimab-bbfg blocks C5 cleavage, preventing C5a and C5b formation and inhibiting terminal complement activation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- CHAPLE disease patent landscape — cliff calendar, originator estates, attackable patents
- CHAPLE disease treatment landscape brief
- CHAPLE disease treatment updates RSS
Frequently asked questions about CHAPLE disease
What drugs treat CHAPLE disease?
Tracked treatments include Veopoz, VEOPOZ.
What is the treatment for CHAPLE disease?
Standard treatment for CHAPLE disease includes Veopoz, VEOPOZ. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: CHAPLE disease patent cliff · CHAPLE disease CI report
- Treatment: Veopoz · Regeneron
- Treatment: VEOPOZ · REGENERON PHARMACEUTICALS
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing